Cellebrite DI Ltd.
CLBT
$19.64
$0.080.41%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | 231.56% | 26.39% | -306.94% | -74.10% | |
| Total Depreciation and Amortization | 4.36% | 0.27% | -13.30% | 3.25% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -89.11% | 0.34% | 509.52% | 164.97% | |
| Change in Net Operating Assets | 87.94% | -188.62% | 7.02% | 203.44% | |
| Cash from Operations | 50.51% | -12.45% | 22.62% | 5,347.84% | |
| Capital Expenditure | -40.62% | -151.27% | -62.47% | 33.62% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -335.58% | -214.52% | 115.04% | 3.47% | |
| Cash from Investing | -604.56% | -209.66% | 108.44% | 7.64% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 48.57% | -41.57% | 128.33% | 20.80% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 48.57% | -41.57% | 128.33% | 20.80% | |
| Foreign Exchange rate Adjustments | -254.29% | -800.00% | -66.65% | 74.09% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 5.45% | -234.22% | 1,603.51% | 473.14% | |